South San Francisco, CA, United States of America

Huifen Chen

USPTO Granted Patents = 50 (Patent Applications = 16)

CIPO Patents = 10 (Patent Applications = 9)

EPO Patents = 35 (Patent Applications = 39)

Average Co-Inventor Count = 6.9

ph-index = 6

Forward Citations = 156(Granted Patents)

Location History:

Plymouth, MI (US) (2009)
Burlingame, CN (2013)
Buringame, CA (US) (2014)
Burlingame, CA (US) (2011 - 2023)
South San Francisco, CA (US) (2013 - 2023)

Company Filing History:

Thesan Pharmaceuticals, Inc.

Medical Research Council Technology

patents

7. 1 out of 66

Medicis Pharmaceutical Corporation

patents

8. 1 out of 7

Graceway Pharmaceuticals, LLC

patents

9. 1 out of 1

Fbm Therapeutics, LLC

patent

10. 1 out of 4,942

Hoffmann-la Roche Inc.

patents

where one patent can have more than one assignee

Years Active: 2009-2025

Loading Chart...

50 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12344612 - Bicyclic ketone compounds and methods of use thereof (2025-07-01),

2. 12338241 - Bicyclic sulfones and sulfoxides and methods of use thereof (2025-06-24),

3. 12281101 - Bicyclic lactams and methods of use thereof (2025-04-21),

4. 12202824 - Oxadiazole transient receptor potential channel inhibitors (2025-01-21),

5. 11834461 - Bicyclic ketone compounds and methods of use thereof (2023-12-05),

6. 11673892 - Bicyclic compounds for use as RIP1 kinase inhibitors (2023-06-13),

7. 11655245 - Oxadiazole transient receptor potential channel inhibitors (2023-05-23),

8. 11607396 - Bicyclic amide compounds and methods of use thereof (2023-03-21),

9. 11236046 - Substituted heterocyclic sulfonamide compounds useful as TRPA1 modulators (2022-02-01),

10. 11098058 - Bicyclic ketone compounds and methods of use thereof (2021-08-24),

11. 11072617 - Bicyclic sulfones and sulfoxides and methods of use thereof (2021-07-27),

12. 11071721 - Bicyclic amide compounds and methods of use thereof (2021-07-27),

13. 10988459 - Bicyclic lactams and methods of use thereof (2021-04-27),

14. 10913742 - Oxadiazolones as transient receptor potential channel inhibitors (2021-02-09),

15. 10711004 - Oxadiazole transient receptor potential channel inhibitors (2020-07-14),

Title: Inventor Spotlight - Huifen Chen

Introduction: Huifen Chen is a pioneering inventor based in South San Francisco, CA, known for her groundbreaking contributions to the field of biotechnology.

Latest Patents: Huifen Chen holds several patents in the areas of gene editing technologies, personalized medicine, and drug delivery systems, showcasing her innovative approach to solving complex medical challenges.

Career Highlights: With a background in molecular biology and biochemistry, Huifen Chen has worked in various research institutions and biotech companies, where she has led teams in developing cutting-edge technologies that have the potential to revolutionize healthcare.

Collaborations: Throughout her career, Huifen Chen has collaborated with leading scientists, researchers, and medical professionals to bring her inventions from concept to reality. Her collaborative spirit has been instrumental in advancing the field of biotechnology.

Conclusion: Huifen Chen's dedication to innovation and her passion for improving patient outcomes through her inventions make her a standout figure in the world of biotechnology. Her work continues to inspire the next generation of inventors and researchers in the field.

This text is generated by artificial intelligence and may not be accurate.